Page last updated: 2024-10-26

3,3'-diindolylmethane and Autosomal Dominant Juvenile Parkinson Disease

3,3'-diindolylmethane has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Research Excerpts

ExcerptRelevanceReference
" We postulated that the pharmacokinetic behavior of C-DIM compounds after oral administration would correlate with neuroprotective efficacy in vivo in a mouse model of Parkinson's disease."1.39Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease. ( Colagiovanni, D; De Miranda, BR; Gustafson, DL; Hansen, RJ; Lunghofer, PJ; Miller, JA; Safe, S; Tjalkens, RB, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Miranda, BR1
Miller, JA1
Hansen, RJ1
Lunghofer, PJ1
Safe, S1
Gustafson, DL1
Colagiovanni, D1
Tjalkens, RB1

Other Studies

1 other study available for 3,3'-diindolylmethane and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 345, Issue:1

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Corpu

2013